Navigation Links
Positive Phase 2 Results Reported with Boehringer Ingelheim's Investigational HCV Protease Inhibitor in Both Previously Treated and Untreated Patients
Date:4/1/2011

5

**Rebound after the end of all assigned treatmentBI 201335 once-daily at 240mg plus SOC provided positive Phase 2 results in this very difficult-to-treat patient population. As is seen in SILEN-C1, a three-day LI with SOC was associated with decreased viral response. Phase 3 trials of BI 201335 are in preparation.

The most frequent dose-dependent AEs in BI 201335 treatment groups were gastrointestinal disorders, jaundice resulting from unconjugated hyperbilirubinemia, and mild to moderate rash or photosensitivity. Serious or severe AEs were reported more frequently in the BI 201335 240mg BID with LI group. Discontinuations due to adverse events ranged from 4 percent in the BI 201335 240mg QD without LI group to 23 percent in the BI 201335 240mg BID with LI group.

Additional HCV Studies to be Presented at EASL

  • SVR and pharmacokinetics of the HCV protease inhibitor BI 201335 with PegIFN/RBV in HCV genotype-1 patients with compensated liver cirrhosis and non-response to previous PegIFN/RBV
    (Poster #1231. S. Pol, et al., April 2, 9:00 a.m.-6:00 p.m. CET)
  • Mechanisms of isolated unconjugated hyperbilirubinemia induced by the HCV NS3/4A protease inhibitor BI 201335
    (Poster #1236. R. Sane, et al., April 2, 9:00 a.m.-6:00 p.m. CET)
  • BI 201335 pharmacokinetics and early effect on viral load in HCV genotype-1 patients
    (Poster #1249. C. Yong, et al., April 2, 9:00 a.m.-6:00 p.m. CET)
  • Preclinical characterization of the hepatitis C virus NS5B polymerase non-nucleoside inhibitor BILB 1941
    (Poster #1215. G. Kukolj, et al., April 2, 9:00 a.m.-6:00 p.m. CET)

  • About Hepatitis C Virus (HCV)HCV is an infectious disease of the liver and is a leading cause of chronic liver disease and liver transplant. The number of individuals chronically infected with HCV globally has been estimated at 170 million, with three to four million new infections occurring each year. Only about 20-45 percent of patient
    '/>"/>

    SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
    2. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
    3. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
    4. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
    5. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    6. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
    7. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
    8. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
    9. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
    10. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
    11. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/23/2014)... DALLAS , September 23, 2014 ... "Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible ... Cardiovascular, Cancer, Ophthalmology, Orthopedics) - Global Forecasts to ... Market over the forecast period of 2014 to ... Billion by 2019, at CAGR of 9.6% from ...
    (Date:9/23/2014)... , Sept. 23, 2014 CASI Pharmaceuticals, Inc. ... to the acquisition, development and commercialization of innovative therapeutics ... global market with a primary focus on ... C. Shrotriya , MD, Chairman and Chief Executive Officer ... The appointment was made in connection with the recently ...
    (Date:9/23/2014)... Sept. 23, 2014 Today, DripDrop, the first ... formation of the DripDrop Foundation, with its primary ... worldwide. Utilizing scientific advancements in Oral Rehydration Therapy ... reduce dehydration and healthcare costs through strategic partnerships, ... "DripDrop has been used in disaster ...
    Breaking Medicine Technology:Ablation Technologies Market Worth $3.81 Billion by 2019 2Ablation Technologies Market Worth $3.81 Billion by 2019 3Ablation Technologies Market Worth $3.81 Billion by 2019 4CASI Pharmaceuticals Announces Appointment Of Rajesh C. Shrotriya, MD To The Board Of Directors 2CASI Pharmaceuticals Announces Appointment Of Rajesh C. Shrotriya, MD To The Board Of Directors 3CASI Pharmaceuticals Announces Appointment Of Rajesh C. Shrotriya, MD To The Board Of Directors 4DripDrop Forms Foundation To Scale Relief Efforts 2
    ... Dec. 3, 2010 Sermo ( http://www.sermo.com ), the ... free Sermo Report titled, " Potential Replacements for Coumadin ... awareness and understanding of these products and potential barriers ... were aware that a new product, Pradaxa (dabigatran etexilate ...
    ... 3, 2010 VIVUS, Inc. (Nasdaq: ... present an overview of the company at two ... presentation schedule is as follows:Canaccord Genuity Cardiovascular, Diabetes ... PTNikko Hotel, San Francisco, CAPresenter: Charles Bowden, MD, ...
    Cached Medicine Technology:Sermo Study shows 70% of Specialists are Ready to Replace Warfarin 2
    (Date:9/23/2014)... The U.S. Pharmacopeial Convention (USP) has submitted ... (WHO) regarding the assignment of Biological Qualifiers (BQ) to ... Expert Group of the Programme of International Nonproprietary Names ... naming of all biologicals that is consistent with existing, ... these drugs. , Hence, USP supports the concept ...
    (Date:9/23/2014)... Dotinga HealthDay Reporter MONDAY, Sept. ... four out of five heart attacks in men, a new study ... to have heart attacks over an average of 11 years if ... diet, exercise and weight fronts, the study found. Only ... this ultra-healthy-living category. But they were 86 percent less likely to ...
    (Date:9/23/2014)... California (PRWEB) September 23, 2014 With ... items, World Gardens Café has added Vegan as an ... come fully prepared and frozen – perfect for busy ... as a fast food meal, these healthy alternatives are ... menu includes meals such as Adobe Tempeh, Caribbean Vegetable ...
    (Date:9/23/2014)... CA (PRWEB) September 23, 2014 Fountain Valley ... has won their latest body transformation contest and been named ... “Jennifer was raised here in Fountain Valley and still resides ... since June 2014 and she recently signed up for one ... been phenomenal,” says owner Zenia Joyner. “In just six weeks, ...
    (Date:9/23/2014)... Recently, Best Cheap Hosting USA, a popular review ... best VPS hosting suppliers in the current market. Among ... hosting is a very popular. The account owner is ... others’ websites under his name, brand or company. , ... primary hosting plans (reseller hosting and low cost shared ...
    Breaking Medicine News(10 mins):Health News:USP Comments to WHO Regarding Biologics Qualifier Proposal 2Health News:Study: Healthy Lifestyle Behaviors May Prevent 80 Percent of Heart Attacks 2Health News:Study: Healthy Lifestyle Behaviors May Prevent 80 Percent of Heart Attacks 3Health News:World Gardens Café Announces Launch of New Vegan Menu 2Health News:Fountain Valley Fit Body Boot Camp Announces Winner of Fitness Boot Camp Ambassador Contest 2Health News:Best Cheap Hosting USA: Bluehost And JustHost Are Ranked As The Best VPS Hosting Suppliers 2
    ... of the wellbeing and inclusion of former politically motivated ... University today (Monday 14 March). Ageing and ... Ireland and the border region of Ireland investigated the ... and republican former prisoners (aged 50 and over) as ...
    ... (March 14, 2011) Research has shown that playing a ... children, but playing a used instrument also can pose a ... instruments were found to be heavily contaminated with a variety ... minor to serious infectious and allergic diseases, according to a ...
    ... , MONDAY, March 14 (HealthDay News) -- Watching this year,s ... for those who bet on the games, one expert suggests. ... sites and spoiler message boards seems to suggest that predicting ... according to Stephen M. Nowlis, a marketing professor at the ...
    ... numerous paths to resist the targeted drug Herceptin, but ... a tumor,s vulnerability to treatment, scientists at The University ... at Nature Medicine . Adding the drug ... cutting off at least five different molecular pathways, each ...
    ... March 11 (HealthDay News) -- People would prefer to allow ... they know others are watching, says a new study. ... think badly of them if they do something wrong rather ... research in the journal Psychological Science . "Omissions ...
    ... (HealthDay News) -- A doctor,s empathy can improve the care ... of being a good doctor, according to a new study. ... 2006 and June 2009 by 29 doctors at Thomas Jefferson ... of empathy for patients, while the quality of patient care ...
    Cached Medicine News:Health News:Report into well-being and inclusion of former politically motivated prisoners 2Health News:Report into well-being and inclusion of former politically motivated prisoners 3Health News:Is your child's hobby making him sick? 2Health News:Combination overcomes breast cancer resistance to herceptin 2Health News:Combination overcomes breast cancer resistance to herceptin 3Health News:When Someone Is Watching, You're Less Inclined to Do Bad Things 2
    Whether you require high flow rates for critical situations or lower rates for others, this insufflator handles both situations equally well, regulated by the preselected pressure....
    The TurboFlow 8000 has two separate gas output ports which, unlike many high flow insufflators, use standard-size tubing, each capable of providing up to 20 LPM flow....
    Tongs...
    ACMI™ COAG Bipolar Laparoscopy Probes provide 360 of hemostatis, bipolar safety, blunt dissection, irrigation, and suction in one instrument....
    Medicine Products: